Bosutinib for Named Patient Import

Bosutinib for Indian Patients

Bosutinib is duly approved medication by the US FDA, recommended by Hematologists worldwide. It is recommended for the therapy of a specific type of blood disorder known as chronic myelogenous leukemia for Philadelphia chromosome-positive patients. Developed and promoted by Pfizer, Bosutinib is known by its trade name or brand Bosulif.

Bosutinib or Bosulif in India can’t be accessed by the patients across the pharmacy counters. Indian agencies are yet to approve this for custom trade and invoicing. It is available as Bosulif 500mg, Bosulif 400mg and Bosulif 100mg tablets in the western markets. Indian Patients can access this medication by securing Named Patient Import and legally import for personal benefit.

Bosutinib in India? We help with access.

Being a patient who is recommended to use Bosulif in India, you can approach genuine sources from various global destinations. Our team can be of great assistance for you to contact such sources who are licensed and with prior experience of exporting products like Bosutinib in India. We also guide the patients in the area of documentation and fulfilling all the necessary legal licensing requirements.

Email at nhs@noelbiotech.com or call us on + 91 9677010046 / + 91 9929277766.